The Global Perfusion Systems Market Size accounted for USD 1.3 Billion in 2022 and is projected to achieve a market size of USD 1.9 Billion by 2032 growing at a CAGR of 4.5% from 2023 to 2032.
Perfusion Systems Market Highlights
- Global Perfusion Systems Market revenue is expected to increase by USD 1.9 Billion by 2032, with a 4.5% CAGR from 2023 to 2032
- North America region led with more than 40% of Perfusion Systems Market share in 2022
- Asia-Pacific Perfusion Systems Market growth will record a CAGR of around 5% from 2023 to 2032
- By End-use, the lithium-ion segment is the largest segment in the market, accounting for over 47% of the market share in 2022
- By components, the electrode segment has recorded more than 38% of the revenue share in 2022
- Rising demand for minimally invasive procedures, drives the Perfusion Systems Market value
Perfusion systems are medical devices used to supply oxygenated blood and nutrients to organs, tissues, or cells outside of the body in order to maintain their viability and function during medical procedures. These systems are commonly employed during surgeries that involve organ transplantation, cardiothoracic procedures, and certain cancer treatments, where the temporary removal of an organ from the body is necessary. Perfusion systems ensure that the removed organ remains well-oxygenated and nourished, reducing the risk of damage and enabling successful transplantation or treatment.
The perfusion systems market has witnessed steady growth in recent years due to several factors. Advances in medical technology and surgical techniques have increased the demand for effective perfusion systems, as more complex procedures become feasible. The growing prevalence of chronic diseases such as cardiovascular disorders and the increasing number of organ transplantations also contribute to the expansion of the market. Additionally, the aging global population has led to a higher incidence of age-related organ failures, driving the need for improved perfusion technologies. As medical science continues to evolve, the market is expected to experience further growth, with innovations in both hardware and software enhancing the efficiency and safety of these systems.
Global Perfusion Systems Market Trends
Market Drivers
- Technological advancements in extracorporeal circulation techniques
- Increasing investments in healthcare infrastructure
- Rising demand for minimally invasive procedures
- Growing research in regenerative medicine and tissue engineering
Market Restraints
- Challenges in maintaining optimal perfusion conditions for different organs
- Limited reimbursement policies for perfusion-related procedures
Market Opportunities
- Expansion of perfusion applications beyond traditional surgeries
- Adoption of telemedicine for remote monitoring and consultation
Perfusion Systems Market Report Coverage
Market |
Perfusion Systems Market
|
Perfusion Systems Market Size 2022 |
USD 1.3 Billion |
Perfusion Systems Market Forecast 2032 |
USD 1.9 Billion |
Perfusion Systems Market CAGR During 2023 - 2032 |
4.5% |
Perfusion Systems Market Analysis Period |
2020 - 2032 |
Perfusion Systems Market Base Year |
2022 |
Perfusion Systems Market Forecast Data |
2023 - 2032 |
Segments Covered |
By Technique, By Component, By Application, By End-use, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Medtronic plc, Terumo Corporation, LivaNova PLC, Getinge AB, Sorin Group, XVIVO Perfusion AB, Organ Assist B.V., Spectrum Medical, Eurosets Srl, Waters Medical Systems LLC, SynCardia Systems, LLC, and Paragonix Technologies, Inc.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Perfusion Systems Market Dynamics
Perfusion systems are advanced medical devices designed to maintain the viability and function of organs, tissues, or cells outside of the body by continuously supplying them with oxygenated blood and essential nutrients. These systems play a crucial role in various medical procedures where temporary removal or isolation of an organ is required, such as organ transplantation, cardiovascular surgeries, and certain cancer treatments. Perfusion systems ensure that the isolated organ remains well-oxygenated, preventing damage and preserving its functionality throughout the procedure.
The applications of perfusion systems are diverse and have revolutionized the field of medicine. One primary application is organ transplantation, where perfusion systems allow for the transportation and assessment of organs before transplantation, significantly extending the window of time in which organs can be utilized. In cardiothoracic surgeries, perfusion systems maintain circulation during procedures like heart surgeries, enabling surgeons to work on a still and bloodless field. Moreover, perfusion systems find application in research and development, aiding in the study of organs and tissues under controlled conditions, as well as in drug testing and development.
The perfusion systems market has exhibited significant growth in recent years, driven by a convergence of factors that have reshaped the healthcare landscape. One of the primary drivers has been the increasing prevalence of chronic diseases, such as cardiovascular disorders and organ failures, necessitating advanced medical interventions. The demand for perfusion systems has surged as these devices play a crucial role in maintaining the viability of organs during procedures like organ transplantation and cardiothoracic surgeries. Additionally, technological advancements in medical equipment and surgical techniques have propelled the market forward, enhancing the efficiency and safety of perfusion procedures.
Perfusion Systems Market Segmentation
The global Perfusion Systems Market segmentation is based on technique, component, application, end-use, and geography.
Perfusion Systems Market By Technique
- Normothermic Machine Perfusion
- Hypothermic Machine Perfusion
According to the perfusion systems industry analysis, the hypothermic machine perfusion segment accounted for the largest market share in 2022. This technique involves preserving organs at lower temperatures while continuously perfusing them with a specialized solution. The growth of this segment can be attributed to its ability to significantly improve organ preservation compared to traditional methods, leading to enhanced transplant success rates. Hypothermic machine perfusion's capacity to mitigate ischemic damage, extend the preservation window, and facilitate assessment of organ viability has spurred its adoption in various transplant scenarios. One of the primary factors contributing to the segment's growth is its potential to address critical challenges in organ transplantation.
Perfusion Systems Market By Component
- Oxygenators
- Bioreactor Perfusion System
- Heart-Lung Machine
- Monitoring System
- Perfusion Pumps
- Others
In terms of components, the oxygenators segment is expected to witness significant growth in the coming years. Oxygenators are essential components that facilitate the exchange of oxygen and carbon dioxide in the blood, ensuring adequate oxygenation of the patient's blood outside of the body. This segment's growth can be attributed to the increasing demand for advanced oxygenators that offer improved gas exchange efficiency, biocompatibility, and ease of integration into perfusion systems. Advancements in medical technology and materials have played a crucial role in propelling the growth of the oxygenators segment.
Perfusion Systems Market By Application
- Cardiopulmonary Perfusion System
- Ex-Vivo Organ Perfusion System
- Cell Perfusion System
According to the perfusion systems market forecast, the cardiopulmonary perfusion system segment is expected to witness significant growth in the coming years. Cardiopulmonary perfusion systems are designed to temporarily take over the functions of the heart and lungs, maintaining blood circulation and oxygenation while the patient's own organs are surgically accessed and treated. The growth of this segment can be attributed to the increasing prevalence of cardiovascular diseases, rising demand for cardiac surgeries, and the continuous pursuit of safer and more efficient surgical techniques. The advancements in both hardware and software components of cardiopulmonary perfusion systems have significantly contributed to their market growth. Improved pump technologies, advanced oxygenators, and enhanced monitoring capabilities have collectively contributed to the successful execution of complex cardiothoracic procedures.
Perfusion Systems Market By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
Based on the end-use, the hospitals segment is expected to continue its growth trajectory in the coming years. Hospitals serve as the primary centers for medical interventions, including organ transplantation, cardiovascular surgeries, and critical care treatments, all of which often require perfusion systems to ensure successful outcomes. As the global burden of chronic diseases and the need for life-saving procedures grow, hospitals' reliance on perfusion systems has intensified, fueling the expansion of this market segment. The growth of the hospitals segment is further supported by ongoing investments in healthcare infrastructure, particularly in both developed and developing economies.
Perfusion Systems Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Perfusion Systems Market Regional Analysis
North America's dominance in the perfusion systems market can be attributed to a combination of factors that have collectively propelled the region to the forefront of this industry. One key driver is the high prevalence of chronic diseases such as cardiovascular disorders and organ failures, necessitating a substantial demand for advanced medical interventions and transplantation procedures. The well-established healthcare infrastructure in North America, with a network of sophisticated hospitals and medical centers, enables efficient integration of perfusion systems into a wide array of medical procedures, further driving market growth. Moreover, North America boasts a robust ecosystem of medical research and innovation, leading to the development of cutting-edge perfusion technologies and techniques. The region is home to numerous renowned research institutions, medical universities, and technology companies that collaborate to push the boundaries of medical science. This environment fosters the creation of innovative perfusion systems that offer enhanced capabilities, such as real-time monitoring, automation, and personalized treatment approaches. The combination of clinical demand and technological innovation has propelled North America's perfusion systems market to a leading position globally.
Perfusion Systems Market Player
Some of the top perfusion systems market companies offered in the professional report include Medtronic plc, Terumo Corporation, LivaNova PLC, Getinge AB, Sorin Group, XVIVO Perfusion AB, Organ Assist B.V., Spectrum Medical, Eurosets Srl, Waters Medical Systems LLC, SynCardia Systems, LLC, and Paragonix Technologies, Inc.
CHAPTER 1. Industry Overview of Perfusion Systems Market
1.1. Definition and Scope
1.1.1. Definition of Perfusion Systems
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Perfusion Systems Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Perfusion Systems Market By Technique
1.2.3. Perfusion Systems Market By Component
1.2.4. Perfusion Systems Market By Application
1.2.5. Perfusion Systems Market By End-use
1.2.6. Perfusion Systems Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Perfusion Systems Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Perfusion Systems Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Perfusion Systems Market By Technique
5.1. Introduction
5.2. Perfusion Systems Revenue By Technique
5.2.1. Perfusion Systems Revenue (USD Billion) and Forecast, By Technique, 2020-2032
5.2.2. Normothermic Machine Perfusion
5.2.2.1. Normothermic Machine Perfusion Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Hypothermic Machine Perfusion
5.2.3.1. Hypothermic Machine Perfusion Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Perfusion Systems Market By Component
6.1. Introduction
6.2. Perfusion Systems Revenue By Component
6.2.1. Perfusion Systems Revenue (USD Billion) and Forecast, By Component, 2020-2032
6.2.2. Oxygenators
6.2.2.1. Oxygenators Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Bioreactor Perfusion System
6.2.3.1. Bioreactor Perfusion System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Heart-Lung Machine
6.2.4.1. Heart-Lung Machine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Monitoring System
6.2.5.1. Monitoring System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Perfusion Pumps
6.2.6.1. Perfusion Pumps Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Others
6.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Perfusion Systems Market By Application
7.1. Introduction
7.2. Perfusion Systems Revenue By Application
7.2.1. Perfusion Systems Revenue (USD Billion) and Forecast, By Application, 2020-2032
7.2.2. Cardiopulmonary Perfusion System
7.2.2.1. Cardiopulmonary Perfusion System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Ex-Vivo Organ Perfusion System
7.2.3.1. Ex-Vivo Organ Perfusion System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Cell Perfusion System
7.2.4.1. Cell Perfusion System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Perfusion Systems Market By End-use
8.1. Introduction
8.2. Perfusion Systems Revenue By End-use
8.2.1. Perfusion Systems Revenue (USD Billion) and Forecast, By End-use, 2020-2032
8.2.2. Hospitals
8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Ambulatory Surgical Centers
8.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Others
8.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Perfusion Systems Market By Country
9.1. North America Perfusion Systems Market Overview
9.2. U.S.
9.2.1. U.S. Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.2.2. U.S. Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
9.2.3. U.S. Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.4. U.S. Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.3. Canada
9.3.1. Canada Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.3.2. Canada Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
9.3.3. Canada Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.4. Canada Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Perfusion Systems Market By Country
10.1. Europe Perfusion Systems Market Overview
10.2. U.K.
10.2.1. U.K. Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.2.2. U.K. Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
10.2.3. U.K. Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.4. U.K. Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.3. Germany
10.3.1. Germany Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.3.2. Germany Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
10.3.3. Germany Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.4. Germany Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.4. France
10.4.1. France Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.4.2. France Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
10.4.3. France Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.4. France Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.5. Spain
10.5.1. Spain Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.5.2. Spain Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
10.5.3. Spain Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.4. Spain Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.6.2. Rest of Europe Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
10.6.3. Rest of Europe Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Perfusion Systems Market By Country
11.1. Asia Pacific Perfusion Systems Market Overview
11.2. China
11.2.1. China Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.2.2. China Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
11.2.3. China Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.4. China Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.3. Japan
11.3.1. Japan Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.3.2. Japan Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
11.3.3. Japan Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.4. Japan Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.4. India
11.4.1. India Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.4.2. India Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
11.4.3. India Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.4. India Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.5. Australia
11.5.1. Australia Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.5.2. Australia Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
11.5.3. Australia Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
11.5.4. Australia Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.6. South Korea
11.6.1. South Korea Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.6.2. South Korea Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
11.6.3. South Korea Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
11.6.4. South Korea Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.7.2. Rest of Asia-Pacific Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
11.7.3. Rest of Asia-Pacific Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Perfusion Systems Market By Country
12.1. Latin America Perfusion Systems Market Overview
12.2. Brazil
12.2.1. Brazil Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
12.2.2. Brazil Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
12.2.3. Brazil Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.4. Brazil Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.3. Mexico
12.3.1. Mexico Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
12.3.2. Mexico Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
12.3.3. Mexico Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.4. Mexico Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
12.4.2. Rest of Latin America Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
12.4.3. Rest of Latin America Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Perfusion Systems Market By Country
13.1. Middle East & Africa Perfusion Systems Market Overview
13.2. GCC
13.2.1. GCC Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
13.2.2. GCC Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
13.2.3. GCC Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.4. GCC Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.3. South Africa
13.3.1. South Africa Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
13.3.2. South Africa Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
13.3.3. South Africa Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.4. South Africa Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Perfusion Systems Revenue (USD Billion) and Forecast By Technique, 2020-2032
13.4.2. Rest of Middle East & Africa Perfusion Systems Revenue (USD Billion) and Forecast By Component, 2020-2032
13.4.3. Rest of Middle East & Africa Perfusion Systems Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Perfusion Systems Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Perfusion Systems Market
14.1. Perfusion Systems Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Perfusion Systems Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Medtronic plc
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Medtronic plc 2022 Perfusion Systems Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Terumo Corporation
15.3. LivaNova PLC
15.4. Getinge AB
15.5. Sorin Group
15.6. XVIVO Perfusion AB
15.7. Organ Assist B.V.
15.8. Spectrum Medical
15.9. Eurosets Srl
15.10. Waters Medical Systems LLC
15.11. SynCardia Systems, LLC
15.12. Paragonix Technologies, Inc